Log in
Enquire now
‌

US Patent 11045472 Quinazoline-pyridine derivatives for the treatment of cancer-related disorders

Patent 11045472 was granted and assigned to Arcus Biosciences on June, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Arcus Biosciences
Arcus Biosciences
0
Current Assignee
Arcus Biosciences
Arcus Biosciences
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
110454720
Patent Inventor Names
Rhiannon Thomas-Tran0
Ehesan Ul Sharif0
Jay Patrick Powers0
Manmohan Reddy Leleti0
Brandon Reid Rosen0
Dillon Harding Miles0
Date of Patent
June 29, 2021
0
Patent Application Number
166108120
Date Filed
May 3, 2018
0
Patent Primary Examiner
‌
Emily A Bernhardt
0
Patent abstract

Compounds of Formula I that inhibit at least one of the A2A and A2B adenosine receptors, and compositions containing compounds of Formula I and methods for synthesizing compounds of Formula I, are described herein.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11045472 Quinazoline-pyridine derivatives for the treatment of cancer-related disorders

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.